Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium

Author:

Bosetti C.,Rosato V.,Li D.,Silverman D.,Petersen G.M.,Bracci P.M.,Neale R.E.,Muscat J.,Anderson K.,Gallinger S.,Olson S.H.,Miller A.B.,Bas Bueno-de-Mesquita H.,Scelo G.,Janout V.,Holcatova I.,Lagiou P.,Serraino D.,Lucenteforte E.,Fabianova E.,Baghurst P.A.,Zatonski W.,Foretova L.,Fontham E.,Bamlet W.R.,Holly E.A.,Negri E.,Hassan M.,Prizment A.,Cotterchio M.,Cleary S.,Kurtz R.C.,Maisonneuve P.,Trichopoulos D.,Polesel J.,Duell E.J.,Boffetta P.,La Vecchia C.,Ghadirian P.

Funder

Italian Association for Cancer Research (AIRC

the COST Action (BM1214) EU-Pancreas

Grant Agency of Ministry of Health of the Czech Republic

MH CZ—DRO

Italian Association for Cancer Research. The Louisiana State University study was supported by the Louisiana Board of Regents Millennium Trust Health Excellence Fund

The National Institutes of Health (NIH) US

NIH Research Project Grant Program

Prevention, Control, and Population Research Goldstein Award; the Society of MSKCC

Geoffrey Beene Cancer Research Fund

Intramural Research Program of the National Institute of Health

National Cancer Institute, Division of Cancer Epidemiology and Genetics

National Institutes of Health

National Health and Medical Research Council

Cancer Research Society

National Cancer Institute of Canada, and the Netherlands contribution was supported by the Dutch Ministry of Public Health, Welfare and Sports

the Lustgarten Foundation for Pancreatic Cancer Research, and the Ontario Cancer Research Network

National Cancer Institute

Rombauer Pancreatic Cancer Research Fund

California Department of Public Health, the National Cancer Institute's Surveillance,

Epidemiology and End Results Program

Red Temática de Investigación Cooperativa en Cáncer (RTICC;

the Generalitat de Catalunya. REN was funded by a National Health and Medical Research Council (Australia) Senior Research Fellowship

Publisher

Elsevier BV

Subject

Oncology,Hematology

Cited by 210 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3